Categories: aggregated

New THC-CBD Pill for MS and Huntington’s Disease May Be First to Benefit from Biden’s New Marijuana Research Bill

In related news, President Biden signed the Marijuana Research and Expansion Act into law. This will speed up researchers’ bids for DEA schedule 1 registration authorization to undertake these trials. After seven hard years of waiting, the MMJ group of firms can finish their mission of performing clinical studies on Huntington’s Disease and Multiple Sclerosis. MMJ has received FDA Orphan Designation for its Huntington’s disease clinical trials.

Jason

Share
Published by
Jason

Recent Posts

The Red Wall Blocking Marijuana Legalization in America, Real or Imagined?

As the movement for marijuana legalization gains momentum across the United States, a significant barrier…

17 hours ago

Autoimmune Conditions Are Rising Fast in American Medicine, Can Cannabis Help?

Conventional treatments prescribed to treat autoimmune conditions are focused on taming inflammation; these usually include…

17 hours ago

Ohio Non-Medical Cannabis is available at Verilife

Verilife Non-Medical Cannabis is now available in Ohio. Open to customers 21+ with a valid…

2 days ago

Find Verilife in New York

At Verilife, there's always a stocked selection of top products & new favorites. Find the…

2 days ago

Find Verilife in Illinois

At Verilife, there's always a stocked selection of top products & new favorites. Find the…

2 days ago